Home biotechs
 

Keywords :   


Tag: biotechs

M&A In Small-, Mid-Cap Biotechs Isn't Slowing Down

2015-12-14 20:08:05| Biotech - Topix.net

Michael Yee of RBC Capital Markets commented in a note that M&A activity within small- and mid-cap healthcare companies "doesn't seem to be slowing down much." Yee added that "good" late-stage and de-risked drugs should command a high value, regardless of any political uncertainty.

Tags: small slowing midcap biotechs

 

BioMarin's FDA Panel: Revisiting Biotech's Biggest Battle

2015-11-30 16:10:16| Biotech - Topix.net

BioMarin's exon-skipping drug, drisapersen, has occupied biotechnology investors' minds over the past week. is a debilitating muscular disease that affects boys less than 10 years of age and slowly causes progressive muscle wasting resulting in loss of walking ability, and respiratory and cardiac failure with 100% death rate within few years.

Tags: panel battle biggest fda

 
 

Acacia pulls IPO as European biotechs caught in U.S. downdraft

2015-10-17 03:52:59| Biotech - Topix.net

Acacia is the latest European biotech company to be caught in a downdraft from the U.S. pharmaceutical and biotechnology sector, which has suffered a major sell-off on mounting concerns about pressure on drug prices. Acacia's decision not to go ahead with its flotation is a particular blow given the size of the planned offering.

Tags: us european caught ipo

 

Wall Street rises as biotechs rebound; oil snaps 3-day rally

2015-10-08 03:45:54| Biotech - Topix.net

World stock indexes rose on Wednesday with a rebound in biotechnology shares boosting US equities, while oil prices snapped a three-day rally after US data showed a large inventory build. The S&P 500 hit its highest in three weeks, but concern about corporate earnings just ahead of the US third-quarter reporting season kept trading choppy.

Tags: street wall oil wall street

 

Biotechs sell off, drag health-care sector lower

2015-10-06 09:01:00| Biotech - Topix.net

Health-care sector stocks gave up early gains and turned negative in afternoon trade Monday, driven by solid losses in biotechnology stocks, while the broader stock market continued to climb. The S&P 500 health-care sector is the only one in negative territory, down 0.4%, while the broader market is up 1.5% to 1,980.

Tags: sell lower sector healthcare

 

Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] next »